Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
29/04/2025
Steel plate sector started to rise, with LiuGang Stock and Guangdong Mingzhu both hitting the limit up, Youfa Group rising by over 5%, TaiGang Stainless, Anyang Iron and Steel, and Baosteel following the uptrend.
Latest
1 m ago
Shiji Information: Net profit in the first quarter of 2025 was 21.1123 million yuan, a year-on-year increase of 85.36%.
1 m ago
The total customer deposits of Zhejiang Merchants Bank have exceeded 2 trillion yuan.
1 m ago
According to a news flash from Bloomberg AI, Tianfeng Securities released a research report on April 29th giving a buy rating to Weixing Materials (002372.SZ). The rating reasons mainly include: 1) Q1 revenue and profit slightly under pressure, still optimistic about the company's medium and long-term development potential; 2) Q1 gross margin under pressure compared to the same period last year, fierce industry competition; 3) Expense rate increase dragging down profits, excellent cash flow performance. (Daily Economic News)
1 m ago
Pfizer expects to incur approximately $1.6 billion in one-time costs to achieve additional savings by 2027.
1 m ago
Pfizer expects to incur approximately $1.6 billion in one-time costs to achieve additional savings by 2027.
See all latest